Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Smith & Nephew plc (SNN) vs Stanley Black & Decker, Inc. (SWK) Price & Performance

Smith & Nephew plcTrade
Stanley Black & Decker, Inc.Trade

Price performance (Past 24H)

Key statistics

Smith & Nephew plc vs Stanley Black & Decker, Inc. — how do they compare? Smith & Nephew plc trades at $27.05 (market cap $11.10B), while Stanley Black & Decker, Inc. trades at $88.4 (market cap $13.47B). The key difference: Stanley Black & Decker, Inc. is the larger of the two by market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.77%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 120 Days and Stanley Black & Decker, Inc. for 62 Days on average.

SNNSWK
Market Cap
$11.10B$13.47B
Volume
1,051,7032,859,744
Sector
HealthIndustrials
52-Week High
$37.17$104.00
52-Week Low
$26.42$62.12
Typical Hold Time
120 Days62 Days
Enterprise Value
$14.13B$17.63B
Dividend Yield
2.95%3.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Smith & Nephew plc

SNN trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue and net income have grown steadily, reaching $6.16B and $625M in 2025, respectively, with improving margins. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. However, cash flow volatility and mixed analyst sentiment pose challenges.

The stock presents a value opportunity with reasonable valuation ratios (P/E 18.34, P/S 1.85), but risks include competitive pressures and recent CFO departure. Analyst consensus is cautious, with 65% hold ratings. Upside depends on execution of growth initiatives amid market headwinds.

Stanley Black & Decker, Inc.

Stanley Black & Decker (SWK) trades at $88.31, down 1.87% on the day, with a bearish technical signal from moving averages and oscillators. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results expected November 4, 2026. Fundamentals show modest revenue of $15.13B in 2025 and a net income margin of 4.07%, while valuation ratios like a P/E of 21.8 and P/S of 0.89 suggest reasonable pricing. Recent news highlights product launches like the dustbuster® mini™ and management's focus on margin gains.

The outlook is mixed: analyst consensus is a 'Hold' with a $93 price target, implying ~5% upside, but technical weakness and competitive pressures pose risks. Investment appeal lies in its dividend king status and cost-saving initiatives, though investors face headwinds from higher expenses and market volatility. Earnings growth remains the key catalyst for further upside.

Returns comparison

Trailing returns across standard periods

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →

About Stanley Black & Decker, Inc.

Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.

Read more on SWK →